XML 107 R92.htm IDEA: XBRL DOCUMENT v3.25.0.1
Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]                      
Loss from continuing operations                 $ (61,623) $ (113,040) $ (18,701)
Loss from discontinued operations, net of tax [1]                 0 0 (463)
Loss before preferred dividends and accretion of Series A Preferred Stock $ (22,802) $ (23,137) $ 1,596 $ (17,280) $ (33,411) $ (25,324) $ (34,323) $ (19,982) (61,623) (113,040) (19,164)
Dividends and accretion of Series A Preferred Stock (7,813) (8,094) (7,979) (7,945) (7,984) (7,872) (7,088) (6,276) (31,831) (29,220) 0
Net loss attributable to common shareholders of Evolent Health, Inc. - basic (30,615) (31,231) (6,383) (25,225) (41,395) (33,196) (41,411) (26,258) (93,454) (142,260) (19,164)
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted $ (30,615) $ (31,231) $ (6,383) $ (25,225) $ (41,395) $ (33,196) $ (41,411) $ (26,258) $ (93,454) $ (142,260) $ (19,164)
Weighted-average common shares outstanding - basic (in shares)                 114,682 111,251 93,699
Weighted-average common shares outstanding - diluted (in shares)                 114,682 111,251 93,699
Basic and diluted                      
Basic (in dollars per share) $ (0.27) $ (0.27) $ (0.06) $ (0.22) $ (0.36) $ (0.30) $ (0.37) $ (0.24) $ (0.81) $ (1.28) $ (0.20)
Diluted (in dollars per share) $ (0.27) $ (0.27) $ (0.06) $ (0.22) $ (0.36) $ (0.30) $ (0.37) $ (0.24) $ (0.81) $ (1.28) $ (0.20)
[1] Includes $0.5 million loss on disposal of discontinued operations for the year ended December 31, 2022.